Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclosporin for severe ulcerative colitis.

T Naftali1, B Novis, I Pomeranz

  • 1Department of Gastroenterology, Meir Hospital, Kfar Saba. natali@post.tau.ac.il

The Israel Medical Association Journal : IMAJ
|September 9, 2000
PubMed
Summary

Cyclosporin effectively treats severe ulcerative colitis in patients unresponsive to conventional therapy. While 37% achieved long-term remission, some still required surgery, though their condition improved pre-operatively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethephon induced oxidative stress in the olive leaf abscission zone enables development of a selective abscission compound.

BMC plant biology·2017
Same author

Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trial.

The American journal of gastroenterology·2015
Same author

Outcomes of a prospective multi-center trial of a second-generation composite mesh for open ventral hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2013
Same author

Zuclopenthixol, D(1)/D(2) antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Nonspecific esophageal motility disorders may be an early stage of a specific disorder, particularly achalasia.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2009
Same author

Patient satisfaction with endoscopy measurement and assessment.

Digestive diseases (Basel, Switzerland)·2008

Area of Science:

  • Gastroenterology
  • Immunosuppressive therapy
  • Inflammatory bowel disease

Background:

  • Severe ulcerative colitis (UC) often fails to respond to conventional treatments, necessitating colectomy.
  • Cyclosporin has emerged as a potential therapeutic option for such refractory cases.

Purpose of the Study:

  • To evaluate the efficacy and safety of cyclosporin in patients with severe, corticosteroid-resistant ulcerative colitis.
  • To review treatment outcomes across six central Israeli hospitals.

Main Methods:

  • Retrospective review of 32 patients with ulcerative colitis treated with cyclosporin.
  • Disease activity assessed using a clinical index, colonoscopy, and laboratory markers.

Main Results:

Related Experiment Videos

  • Intravenous cyclosporin treatment (average 12.7 days) significantly reduced disease activity index (14.22 to 4.74) within a mean of 7.5 days.
  • 37% of patients achieved at least 6 months of remission without surgery.
  • 40% required surgery within 6 months, with improved pre-operative condition; 18.8% required later surgery.
  • Numerous side effects were noted, with neurotoxicity leading to withdrawal in one case.

    • Conclusions:

    • Cyclosporin demonstrates relative safety and efficacy for severe ulcerative colitis.
    • It can induce long-term remission in a significant proportion of patients and improve clinical status prior to colectomy.